CountryOfPapers CountryOfPapers
Journal list Promote Sponsor
verified SJR 0,275 · Q3 • database Scopus / SJR & Web of Science indexed
Molecular Imaging and Radionuclide Therapy
Turkey · Galenos Publishing House
workspace_premium Q3 — Radiology, Nuclear Medicine and Imaging visibility_off Double blind peer review lock_open Open Access

Molecular Imaging and Radionuclide Therapy

Molecular Imaging and Radionuclide Therapy is a journal indexed in SJR in Radiology, Nuclear Medicine and Imaging with an H index of 15. It is an CC BY-NC-ND Journal with a Double blind peer review review system The scope of the journal is focused on radionuclide therapy, radionuclide imaging, perfusion imaging, scintigraphy, positron-emission tomography, molecular imaging. It has an SJR impact factor of 0,275 and it has a best quartile of Q3. It is published in English. It has an SJR impact factor of 0,275.

ISSN: 2146-1414
Publisher: Galenos Publishing House
Category: Radiology, Nuclear Medicine and Imaging
Indexation: verifiedScopus / SJR verifiedWeb of Science
open_in_new Portal NPD menu_book Author guidelines
schedule CountryOfPapers database fields
SJR Impact Factor trending_up
0,275 Q3
H-index 15
Acceptance rate pie_chart
52%
Source Acceptance_Rate
Time to publication hourglass_top
16 weeks
Field Average_time_publication_weeks
Publication cost (APC) payments
NPD Open Access
Non-OA path NPD

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,275

H-index

15

Docs (year)

43

Docs 3y

138

Total refs

546

Cites 3y

106

Citable 3y

131

Cites/Doc 2y

0.84

Ref/Doc

12.7

Immediate OA

—

Embargoed OA

NPD

Non OA / Submission

- €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims
rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.
User
* Only to validate authenticity — identity is not shown publicly.

FAQs

What is the SJR of Molecular Imaging and Radionuclide Therapy?

Molecular Imaging and Radionuclide Therapy has an SJR of 0,275 (best quartile Q3) in the CountryOfPapers database.

What is the APC / publication cost?

Immediate OA APC is not available (NPD).

What is the acceptance rate?

The acceptance rate recorded for Molecular Imaging and Radionuclide Therapy is 52%.